FTXHOverviewHoldingsDividends
Fund holdings · First Trust Nasdaq Pharmaceuticals ETF

FTXH holdings: all 50 positions

FTXH held 50 positions as of Oct 13, 2026. AbbVie Inc. is the largest at 7.85%; the top 10 are 55.0% of the fund.

Share
Download CSVFTXH fund page
How much of the fund each position is · one bar per position, largest first
ABBV 7.85%50 positionsLQDA 0.20%
55.0%
top 10 together
7.85%
largest position
25
positions under 1%

Every position

50 of 50 · click a column to sort
FTXH’s 50 positions by weight, from the holdings published by its issuer for Oct 13, 2026. A weight is a share of net assets. Source: First Trust.
#HoldingTickerWeight ↓
1AbbVie Inc.ABBV7.85%
2Eli Lilly and CompanyLLY7.40%
3Pfizer Inc.PFE7.32%
4Merck & Co., Inc.MRK7.05%
5Johnson & JohnsonJNJ6.86%
6Biogen Inc.BIIB3.88%
7Viatris Inc.VTRS3.83%
8Gilead Sciences, Inc.GILD3.71%
9Zoetis Inc.ZTS3.54%
10Amgen Inc.AMGN3.52%
11United Therapeutics CorporationUTHR3.47%
12Regeneron Pharmaceuticals, Inc.REGN3.46%
13Vertex Pharmaceuticals IncorporatedVRTX3.27%
14Incyte CorporationINCY3.20%
15Bristol-Myers Squibb CompanyBMY3.11%
16Jazz Pharmaceuticals PlcJAZZ2.45%
17Exelixis, Inc.EXEL2.43%
18Illumina, Inc.ILMN2.30%
19Halozyme Therapeutics, Inc.HALO1.62%
20Medpace Holdings, Inc.MEDP1.54%
21Alnylam Pharmaceuticals, Inc.ALNY1.18%
22Elanco Animal Health IncorporatedELAN1.18%
23BioMarin Pharmaceutical Inc.BMRN1.17%
24Neurocrine Biosciences, Inc.NBIX1.17%
25Charles River Laboratories International, Inc.CRL1.06%
26Iovance Biotherapeutics, Inc.IOVA0.91%
27Moderna, Inc.MRNA0.79%
2810X Genomics, Inc. (Class A)TXG0.59%
29Caris Life Sciences, Inc.CAI0.59%
30Amneal Pharmaceuticals, Inc.AMRX0.57%
31Twist Bioscience CorporationTWST0.56%
32Ligand Pharmaceuticals Inc. (Class B)LGND0.54%
33Corcept Therapeutics Inc.CORT0.53%
34Adaptive Biotechnologies CorporationADPT0.52%
35Guardant Health, Inc.GH0.52%
36TG Therapeutics, Inc.TGTX0.51%
37Tango Therapeutics, Inc.TNGX0.50%
38Roivant Sciences Ltd.ROIV0.49%
39Protagonist Therapeutics, Inc.PTGX0.48%
40Krystal Biotech, Inc.KRYS0.46%
41Kymera Therapeutics, Inc.KYMR0.46%
42Spyre Therapeutics, Inc.SYRE0.46%
43Alkermes PlcALKS0.43%
44Oruka Therapeutics, Inc.ORKA0.43%
45Travere Therapeutics, Inc.TVTX0.40%
46Dianthus Therapeutics, Inc.DNTH0.37%
47Arrowhead Pharmaceuticals, Inc.ARWR0.36%
48Enliven Therapeutics Inc.ELVN0.35%
49ACADIA Pharmaceuticals Inc.ACAD0.33%
50Liquidia Technologies, Inc.LQDA0.20%
US Dollar0.10%
Cash and other net assets−0.02%
As of Oct 13, 2026. Source: First Trust.

The book

FundFirst Trust Nasdaq Pharmaceuticals ETF
Positions50
Holdings published for (the issuer’s daily file)Oct 13, 2026
SourceFirst Trust ↗
Top 10 together55.0%
Cash and other net assets0.08%

What this list is

How the list is built

Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.

Weights are as the source states them, largest first.

Where to next
FTXH fund page→Overlap of FTXH with another fund→Which ETFs hold a company→Compare two funds→How books are read→
Where these figures came from
First Trust ↗

ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →

Cite this pageCitation, APA and Markdown

ETFIQ, Holdings of FTXH, data as of Oct 13, 2026. https://etfiq.com/funds/ftxh/holdings/

Open data →

Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.